MORRIS PLAINS, N.J., Nov. 7, 2011 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today announced that Gerard G. Gorman, Senior Vice President Finance and Chief Financial Officer, will participate in the Brean Murray, Carret & Co. 2011 Life Sciences Summit on Monday, November 14, 2011, at the Grand Hyatt New York in New York City. This conference will feature 40-minute one-on-one sessions and small group meetings with institutional clients. There will be no formal presentation.
